Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/10/21
End: 11/15/22
Due: 11/15/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China | NCT04954131 | Zhejiang Clover Biopharmaceuticals, Inc. | user2@example.com | None | 2021-08-10 | 2022-11-15 | 2023-11-15 | - | - | 2025-07-14 |